Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
Titel:
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
Auteur:
Burris III, Howard A Okusaka, Takuji Vogel, Arndt Lee, Myung Ah Takahashi, Hidenori Breder, Valeriy Blanc, Jean-Frédéric Li, Junhe Bachini, Melinda Żotkiewicz, Magdalena Abraham, Jayne Patel, Nikunj Wang, Julie Ali, Muzammil Rokutanda, Nana Cohen, Gordon Oh, Do-Youn